SCHEMBL24993367

SCHEMBL24993367

CCOc1ccc(-c2nc(C(=O)NN)cnc2CC)cc1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ CNR1 P21554 9/20 0.44
▸ SCN2A Q99250 3/20 0.44
▸ SCN10A Q9Y5Y9 3/20 0.44
▸ POLB P06746 2/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MITF O75030 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24993371 0.86 ALDH1A1 (0.53) ALDH1A1MAPTCNR1SCN2ASCN10A
SCHEMBL24994714 0.86 NPC1 (0.46) ALDH1A1MAPTCNR1SCN2ASCN10A
SCHEMBL24993372 0.86 ALDH1A1 (0.56) ALDH1A1MAPTCNR1SCN2ASCN10A
SCHEMBL24993339 0.85 MAPT (0.52) ALDH1A1MAPTCNR1SCN2ASCN10A
SCHEMBL24993368 0.82 MAPT (0.49) ALDH1A1MAPTCNR1SCN2ASCN10A
SCHEMBL24993560 0.78 ALDH1A1 (0.54) ALDH1A1MAPTSCN2ASCN10APOLB
SCHEMBL24993306 0.77 SCN10A (0.69) ALDH1A1MAPTSCN2ASCN10APOLB
SCHEMBL25003805 0.75 ALDH1A1 (0.57) ALDH1A1MAPTSCN2ASCN10APOLB
SCHEMBL24994723 0.73 ALDH1A1 (0.48) ALDH1A1MAPTCNR1POLBNPC1
SCHEMBL25003126 0.73 ALDH1A1 (0.51) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback